EOCN · NASDAQ
Galmed Pharmaceuticals (EOCN) Stock Price & Fundamentals
Galmed Pharmaceuticals (EOCN) closed at $572.97 on Oct 9, 2026, down 1.07% from the previous close of $579.18.
Share price, past year
1Y +5.24%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $572.97 |
| Sep 30, 2026 | $573.24 |
| Aug 31, 2026 | $593.61 |
| Jul 31, 2026 | $596.69 |
| Jun 30, 2026 | $563.80 |
| May 29, 2026 | $544.83 |
| Apr 30, 2026 | $556.84 |
| Mar 31, 2026 | $544.03 |
| Feb 27, 2026 | $533.50 |
| Jan 30, 2026 | $511.59 |
| Dec 31, 2025 | $505.19 |
| Nov 28, 2025 | $543.49 |
| Oct 31, 2025 | $534.16 |
Key statistics
- Market cap
- $3.77B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 6.6M
- Dividend yield
- —
- 52-week range
- $499.48 – $623.61
Galmed Pharmaceuticals's market cap is $3.77B, based on a share price of $572.97 and 6.6M shares outstanding as of Dec 31, 2025.
Financials
Galmed Pharmaceuticals reported revenue of $0.00 for fiscal 2020.
Galmed Pharmaceuticals reported a net loss of $10.31M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2020ended Dec 31, 2020 | $0.00 | — | −$28.77M | — | — | −$26.33M |
| FY2019ended Dec 31, 2019 | $0.00 | −100.0% | −$20.46M | — | — | −$14.95M |
| FY2018ended Dec 31, 2018 | $2.04M | +87.8% | — | — | — | −$9.11M |
| FY2017ended Dec 31, 2017 | $1.09M | +132.3% | — | — | — | −$12.08M |
| FY2016ended Dec 31, 2016 | $467.00K | — | — | — | — | −$12.15M |
| FY2015ended Dec 31, 2015 | $0.00 | — | — | — | — | −$8.63M |
| FY2014ended Dec 31, 2014 | $0.00 | — | — | — | — | — |
Company profile
- Name
- Galmed Pharmaceuticals Ltd.
- Ticker
- EOCN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- C/O Meitar Law Offices, 16 Abba Hillel Silver Rd., Ramat Gan, L3 5250608
- Incorporated in
- L3
- Fiscal year ends
- December
- SEC CIK
- 0001595353
Frequently asked questions
What is Galmed Pharmaceuticals's stock price?
Galmed Pharmaceuticals (EOCN) closed at $572.97 on Oct 9, 2026, down 1.07% from the previous close of $579.18.
What is Galmed Pharmaceuticals's market cap?
Galmed Pharmaceuticals's market cap is $3.77B, based on a share price of $572.97 and 6.6M shares outstanding as of Dec 31, 2025.
How much revenue does Galmed Pharmaceuticals make?
Galmed Pharmaceuticals reported revenue of $0.00 for fiscal 2020.
Sources and methodology
Fundamentals come from Galmed Pharmaceuticals Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures